Coronavirus - Medika Life

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Long-Covid Patients Are Frustrated That Federal Research Hasn’t Found New Treatments

Kennedy’s Biggest Challenge Isn’t Vaccines, It’s Medical Indoctrination

The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It

Do Surgical Masks Protect You Against COVID?

LATEST

TRENDING

Reiner Fuellmich Fact Checked and Exposed as a Covid Conspiracy Con

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

We Call Out Reiner Fuellmich as a Fraud. The Covid Conspirator Investigated

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Fact-Checking Geert Vanden Bossche. Cashing in on Covid Misinformation

Exposing America’s Frontline Doctors and Their Financial Empire Built on Hydroxychloroquine

Prof Dolores Cahill is the Latest Quack to Commit Career Suicide

Who Not To Trust: A List of 10 Covid-19 Charlatans and “Medical” Snake-Oil Salesmen

Is Your Covid Test Being Used to Covertly Harvest Your DNA?

Debunking Nicholas Wade’s Origin of COVID Conspiracy Theory

EDITORS CHOICE

We Cannot Succumb to “Pandemic Fatigue”

What is it About Covid That Makes it Worse

What’s Been So Maddening (and Humbling) About Covid-19

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories